211 related articles for article (PubMed ID: 8140505)
1. [Acquired factor VIII inhibitor in a patient with rheumatoid arthritis].
Ruiz-Calderón AJ; Carrasco F; Duro R; Constantino M
Sangre (Barc); 1993 Oct; 38(5):403-5. PubMed ID: 8140505
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
[TBL] [Abstract][Full Text] [Related]
3. [Acquired coagulation factor VIII inhibitor in a non-hemophiliac patient].
Polo Romero FJ; Fernández Fúnez A
Rev Clin Esp; 1999 Feb; 199(2):114-5. PubMed ID: 10216409
[No Abstract] [Full Text] [Related]
4. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
[TBL] [Abstract][Full Text] [Related]
5. A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine.
Hart HC; Kraaijenhagen RJ; Kerckhaert JA; Verdel G; Freen M; van de Wiel A
Transplant Proc; 1988 Jun; 20(3 Suppl 4):323-8. PubMed ID: 3132776
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus.
Lafferty TE; Smith JB; Schuster SJ; DeHoratius RJ
Arthritis Rheum; 1997 Apr; 40(4):775-8. PubMed ID: 9125263
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
Green D; Rademaker AW; Briët E
Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
[TBL] [Abstract][Full Text] [Related]
8. [Remission of a non-haemophilic patient with acquired factor VIII inhibitor treated with infusion of factor VIII and corticosteroid].
Honda J; Egami K; Osabe S; Natori H; Nakamura E; Tanaka K; Naitou K; Kaji M
Rinsho Ketsueki; 1989 Apr; 30(4):520-4. PubMed ID: 2504978
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypes against autoantibodies to procoagulant factor VIII (VIII:C) in intravenous immunoglobulins.
Kazatchkine MD; Rossi F; Sultan Y; Nydegger U
Int Rev Immunol; 1989; 5(2):157-63. PubMed ID: 8691048
[No Abstract] [Full Text] [Related]
10. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
11. Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.
Oliveira B; Arkfeld DG; Weitz IC; Shinada S; Ehresmann G
J Clin Rheumatol; 2007 Apr; 13(2):89-91. PubMed ID: 17414538
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
Mansouritorghabeh H; Lak M; van Heerde WL
Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
[TBL] [Abstract][Full Text] [Related]
13. [Acquired hemophilia and rheumatoid arthritis. Value of intravenous immunoglobulins].
Struillou L; Fiks-Sigaud M; Barrier JH; Blat E; Magadur-Joly G
Rev Rhum Ed Fr; 1993; 60(7-8):524-6. PubMed ID: 8148853
[TBL] [Abstract][Full Text] [Related]
14. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
15. Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritis.
Pignone A; Matucci-Cerinic M; Morfini M; Lombardi A; Rossi Ferrini PL; Cagnoni M
J Intern Med; 1992 Jun; 231(6):617-9. PubMed ID: 1619384
[TBL] [Abstract][Full Text] [Related]
16. [Long-term response to rituximab in a patient with acquired hemophilia].
García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
[TBL] [Abstract][Full Text] [Related]
17. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
18. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
Klare M; Möller T; Hanke P; Weller P; Seige K
Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration.
Yamazaki M; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Nakamura S; Naito T; Ohta H
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):491-5. PubMed ID: 8329575
[TBL] [Abstract][Full Text] [Related]
20. Treatment of factor VIII inhibitors.
Kasper CK
Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
[No Abstract] [Full Text] [Related]
[Next] [New Search]
